$ALMU

Klamkin Jonathan sold $422K of ALMU

Klamkin Jonathan (Chief Executive Officer) sold 20,000 shares of Aeluma, Inc. (ALMU) at an average of $21.08 ($21.08–$21.56, $0.42M total) across 2 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klamkin Jonathan
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALMU
Neutral
medium confidence
Mentioned
$ALMU
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALMUNeutralLow
01

Why it matters

The only new information is the disclosed sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; there is no accompanying corporate event.

02

Market read

Traders may note the insider selling signal, but the 10b5-1 framing reduces the likelihood of a fundamental re-rating from this single filing.

03

What to watch

The filing does not disclose reasons for the sale, and the weighted-average price range ($21.0810 to $21.5600) may reflect normal execution timing rather than a view on valuation.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-02 for trades dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for Aeluma, Inc. (ALMU).

Company-level read

Ticker impact

$ALMUNeutralMedium confidence
Context

Aeluma CEO Jonathan Klamkin sold about 20,000 shares in open-market transactions under a 10b5-1 plan, totaling $421,667.90.

Expected impact

Likely limited near-term impact; any effect would be short-lived unless followed by additional disclosures.

Evidence & confidence

Form 4 shows a planned sale (10b5-1) with no accompanying company-specific news, guidance, or operational change.

Market effects

No clear sector read-through from a single planned insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales under 10b5-1 can reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • Aeluma, Inc.

    Company whose CEO insider sale is disclosed via SEC Form 4.

  • Jonathan Klamkin

    Chief Executive Officer and director who sold shares under a 10b5-1 plan.

Related articles

$ALMUMed

The Speed of Light: 5 Stocks Powering AI’s Optical Future

MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and

$ALMUMedAI 8/10

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Aeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.